STRS Ohio’s Climb Bio CLYM Stock Holding History

STRS Ohio’s Portfolio CLYM Stock Details CLYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Buy	+15,300	New	+$158K	﹤0.01%	1589
2025 Q2	–	Sell	-5,300	Closed	-$6.47K	–	2325
2025 Q1	$6.47K	Hold	5,300	–	–	﹤0.01%	1891
2024 Q4	$9.54K	Hold	5,300	–	–	﹤0.01%	1848
2024 Q3	$27K	Hold	5,300	–	–	﹤0.01%	1876
2024 Q2	$37.7K	Buy	+5,300	New	+$35.3K	﹤0.01%	1828
2022 Q2	–	Sell	-1,600	Closed	-$13K	–	2332
2022 Q1	$13K	Hold	1,600	–	–	﹤0.01%	2075
2021 Q4	$16K	Hold	1,600	–	–	﹤0.01%	2139
2021 Q3	$28K	Buy	+1,600	New	+$33.1K	﹤0.01%	2156

Other funds holding CLYM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

STRS Ohio's CLYM Position: Q2 2026 in Review

STRS Ohio opened a new position in Climb Bio (CLYM) in Q2 2026: 15,300 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #1589 among its holdings. This is a return to the name: STRS Ohio previously reported a position in CLYM as recently as Q1 2025.

STRS Ohio first reported a position in CLYM in Q3 2021 and has held it in 8 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

STRS Ohio held 15,300 shares of Climb Bio worth $200K as of Q2 2026.
Climb Bio was a new STRS Ohio position in Q2 2026.
Climb Bio made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1589 holding.
STRS Ohio first reported a position in Climb Bio in Q3 2021 and has held it in 8 quarters since.
109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.